Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who have inexorable progression of pulmonary fibrosis despite treatment, which is known as the progressive fibrotic phenotype. Although the concept of progressive fibrosing ILD has been applied largely to pati...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September 2020
|
| In: |
The lancet. Respiratory medicine
Year: 2020, Jahrgang: 8, Heft: 9, Pages: 925-934 |
| ISSN: | 2213-2619 |
| DOI: | 10.1016/S2213-2600(20)30355-6 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S2213-2600(20)30355-6 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2213260020303556 
|
| Verfasserangaben: | Peter M George, Paolo Spagnolo, Michael Kreuter, Goksel Altinisik, Martina Bonifazi, Fernando J Martinez, Philip L Molyneaux, Elisabetta A Renzoni, Luca Richeldi, Sara Tomassetti, Claudia Valenzuela, Carlo Vancheri, Francesco Varone, Vincent Cottin, Ulrich Costabel, the Erice ILD working group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1747692255 | ||
| 003 | DE-627 | ||
| 005 | 20230426111216.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210205s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2213-2600(20)30355-6 |2 doi | |
| 035 | |a (DE-627)1747692255 | ||
| 035 | |a (DE-599)KXP1747692255 | ||
| 035 | |a (OCoLC)1341390240 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a George, Peter M. |e VerfasserIn |0 (DE-588)122648834X |0 (DE-627)1747697540 |4 aut | |
| 245 | 1 | 0 | |a Progressive fibrosing interstitial lung disease |b clinical uncertainties, consensus recommendations, and research priorities |c Peter M George, Paolo Spagnolo, Michael Kreuter, Goksel Altinisik, Martina Bonifazi, Fernando J Martinez, Philip L Molyneaux, Elisabetta A Renzoni, Luca Richeldi, Sara Tomassetti, Claudia Valenzuela, Carlo Vancheri, Francesco Varone, Vincent Cottin, Ulrich Costabel, the Erice ILD working group |
| 264 | 1 | |c September 2020 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.02.2021 | ||
| 520 | |a Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who have inexorable progression of pulmonary fibrosis despite treatment, which is known as the progressive fibrotic phenotype. Although the concept of progressive fibrosing ILD has been applied largely to patients with idiopathic pulmonary fibrosis (IPF), there is now an increasing focus on irreversible progressive fibrosis in a proportion of patients with a range of underlying ILD diagnoses. Evidence has emerged to support a possible role for antifibrotic therapy in these patients. In this Position Paper, we discuss the importance of retaining diagnostic scrutiny within the multidisciplinary team and suggest a multidomain definition for progressive fibrosis. We consider the potential role of antifibrotic drugs as second-line therapy in the treatment algorithm for patients with progressive non-IPF ILD. We highlight risk factors that might predispose individuals to developing progressive fibrosis. Finally, we discuss key uncertainties and future directions for research and clinical practice. | ||
| 700 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet. Respiratory medicine |d Oxford : Elsevier, 2013 |g 8(2020), 9, Seite 925-934 |w (DE-627)737292180 |w (DE-600)2704917-6 |w (DE-576)379472759 |x 2213-2619 |7 nnas |a Progressive fibrosing interstitial lung disease clinical uncertainties, consensus recommendations, and research priorities |
| 773 | 1 | 8 | |g volume:8 |g year:2020 |g number:9 |g pages:925-934 |g extent:10 |a Progressive fibrosing interstitial lung disease clinical uncertainties, consensus recommendations, and research priorities |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S2213-2600(20)30355-6 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2213260020303556 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210205 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1747692255 |e 3849488527 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"subtitle":"clinical uncertainties, consensus recommendations, and research priorities","title":"Progressive fibrosing interstitial lung disease","title_sort":"Progressive fibrosing interstitial lung disease"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2013 -"],"part":{"issue":"9","volume":"8","extent":"10","year":"2020","pages":"925-934","text":"8(2020), 9, Seite 925-934"},"recId":"737292180","note":["Gesehen am 01.04.14"],"id":{"zdb":["2704917-6"],"eki":["737292180"],"issn":["2213-2619"]},"titleAlt":[{"title":"The lancet <London> / Respiratory medicine"}],"disp":"Progressive fibrosing interstitial lung disease clinical uncertainties, consensus recommendations, and research prioritiesThe lancet. Respiratory medicine","language":["eng"],"origin":[{"dateIssuedKey":"2013","publisherPlace":"Oxford","publisher":"Elsevier","dateIssuedDisp":"2013-"}],"title":[{"partname":"Respiratory medicine","title_sort":"lancet","title":"The lancet"}]}],"physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Peter M George, Paolo Spagnolo, Michael Kreuter, Goksel Altinisik, Martina Bonifazi, Fernando J Martinez, Philip L Molyneaux, Elisabetta A Renzoni, Luca Richeldi, Sara Tomassetti, Claudia Valenzuela, Carlo Vancheri, Francesco Varone, Vincent Cottin, Ulrich Costabel, the Erice ILD working group"]},"id":{"doi":["10.1016/S2213-2600(20)30355-6"],"eki":["1747692255"]},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"September 2020"}],"language":["eng"],"person":[{"display":"George, Peter M.","role":"aut","roleDisplay":"VerfasserIn","given":"Peter M.","family":"George"},{"family":"Kreuter","roleDisplay":"VerfasserIn","role":"aut","given":"Michael","display":"Kreuter, Michael"}],"recId":"1747692255","note":["Gesehen am 05.02.2021"],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a GEORGEPETEPROGRESSIV2020 | ||